{"pmid":32357575,"title":"COVID-19: A Geriatric Emergency.","text":["COVID-19: A Geriatric Emergency.","The older Italian population is posing a challenge in the number of deaths for coronavirus disease 2019 (COVID-19). According to previous data from China, pre-existing health conditions dramatically increase the risk of dying from COVID-19. The presence of multiple diseases in older patients may be considered as a mark of frailty, which increases the person's vulnerability to stress and impairs the multisystemic compensatory effort to restore homeostasis. The clinical complexity associated with the management of frailty may increase the risk of complications during infection as well as the lack of the early recognition of atypical symptoms. There is an urgent need to share expertise and clinical management skills with geriatricians as well as the need for early diagnosis to start treatment at the earliest convenience in the community, with the aim to avoid the collapse of intensive care units.","Geriatrics (Basel)","Boccardi, Virginia","Ruggiero, Carmelinda","Mecocci, Patrizia","32357575"],"abstract":["The older Italian population is posing a challenge in the number of deaths for coronavirus disease 2019 (COVID-19). According to previous data from China, pre-existing health conditions dramatically increase the risk of dying from COVID-19. The presence of multiple diseases in older patients may be considered as a mark of frailty, which increases the person's vulnerability to stress and impairs the multisystemic compensatory effort to restore homeostasis. The clinical complexity associated with the management of frailty may increase the risk of complications during infection as well as the lack of the early recognition of atypical symptoms. There is an urgent need to share expertise and clinical management skills with geriatricians as well as the need for early diagnosis to start treatment at the earliest convenience in the community, with the aim to avoid the collapse of intensive care units."],"journal":"Geriatrics (Basel)","authors":["Boccardi, Virginia","Ruggiero, Carmelinda","Mecocci, Patrizia"],"date":"2020-05-03T11:00:00Z","year":2020,"_id":"32357575","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.3390/geriatrics5020024","keywords":["covid-19","aging","frailty","geriatrics","older"],"locations":["Italian","China"],"countries":["Italy","China"],"countries_codes":["ITA|Italy","CHN|China"],"topics":["Prevention"],"weight":1,"_version_":1666138495316393988,"score":9.490897,"similar":[{"pmid":32446793,"title":"Coronavirus: the geriatric emergency of 2020. Joint document of the Section on Geriatric Cardiology of the Spanish Society of Cardiology and the Spanish Society of Geriatrics and Gerontology.","text":["Coronavirus: the geriatric emergency of 2020. Joint document of the Section on Geriatric Cardiology of the Spanish Society of Cardiology and the Spanish Society of Geriatrics and Gerontology.","SARS-CoV-2 infection, also known as COVID-19 (coronavirus infectious disease-19), was first identified in December 2019. In Spain, the first case of this infection was diagnosed on 31 January, 2020 and, by 15 April 2020, has caused 18 579 deaths, especially in the elderly. Due to the rapidly evolving situation regarding this disease, the data reported in this article may be subject to modifications. The older population are particularly susceptible to COVID-19 infection and to developing severe disease. The higher morbidity and mortality rates in older people have been associated with comorbidity, especially cardiovascular disease, and frailty, which weakens the immune response. Due to both the number of affected countries and the number of cases, the current situation constitutes an ongoing pandemic and a major health emergency. Because Spain has one of the largest older populations in the world, COVID-19 has emerged as a geriatric emergency. This document has been prepared jointly between the Section on Geriatric Cardiology of the Spanish Society of Cardiology and the Spanish Society of Geriatrics and Gerontology.","Rev Esp Cardiol (Engl Ed)","Bonanad, Clara","Garcia-Blas, Sergio","Tarazona-Santabalbina, Francisco Jose","Diez-Villanueva, Pablo","Ayesta, Ana","Sanchis Fores, Juan","Vidan-Austiz, Maria Teresa","Formiga, Francesc","Ariza-Sole, Albert","Martinez-Selles, Manuel","32446793"],"abstract":["SARS-CoV-2 infection, also known as COVID-19 (coronavirus infectious disease-19), was first identified in December 2019. In Spain, the first case of this infection was diagnosed on 31 January, 2020 and, by 15 April 2020, has caused 18 579 deaths, especially in the elderly. Due to the rapidly evolving situation regarding this disease, the data reported in this article may be subject to modifications. The older population are particularly susceptible to COVID-19 infection and to developing severe disease. The higher morbidity and mortality rates in older people have been associated with comorbidity, especially cardiovascular disease, and frailty, which weakens the immune response. Due to both the number of affected countries and the number of cases, the current situation constitutes an ongoing pandemic and a major health emergency. Because Spain has one of the largest older populations in the world, COVID-19 has emerged as a geriatric emergency. This document has been prepared jointly between the Section on Geriatric Cardiology of the Spanish Society of Cardiology and the Spanish Society of Geriatrics and Gerontology."],"journal":"Rev Esp Cardiol (Engl Ed)","authors":["Bonanad, Clara","Garcia-Blas, Sergio","Tarazona-Santabalbina, Francisco Jose","Diez-Villanueva, Pablo","Ayesta, Ana","Sanchis Fores, Juan","Vidan-Austiz, Maria Teresa","Formiga, Francesc","Ariza-Sole, Albert","Martinez-Selles, Manuel"],"date":"2020-05-25T11:00:00Z","year":2020,"_id":"32446793","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1016/j.rec.2020.05.001","keywords":["covid-19","emergencia mundial","geriatrics","geriatria","pandemia","pandemic","worldwide emergency"],"locations":["Spain","Spain"],"countries":["Spain"],"countries_codes":["ESP|Spain"],"topics":["Prevention"],"weight":1,"_version_":1667698385865408512,"score":211.70126},{"pmid":32387139,"title":"A dual-centre observational review of hospital based palliative care in patients dying with COVID-19.","text":["A dual-centre observational review of hospital based palliative care in patients dying with COVID-19.","The current Covid-19 pandemic has put significant strain on all aspects of healthcare delivery, including palliative care services. Given the high mortality from this disease, particularly in the more vulnerable members of society, it is important to examine how best to deliver a high standard of end of life care during this crisis. This case series collected data from two acute hospitals examining the management of patients diagnosed with Covid-19 who subsequently died (n=36) and compared this to national and local end of life audit data for all other deaths. Our results demonstrated a shorter dying phase (38.25 hours vs 74 hours) and higher rates of syringe driver use (72% vs 33% in local audits), although with similar average mediation doses. Of note was the significant heterogeneity in the phenotype of deterioration in the dying phase, two distinct patterns emerged, with one group demonstrating severe illness with a short interval between symptom onset and death and another group presenting with a more protracted deterioration. This brief report suggests a spectrum of mode of dying. Over all the cohort reflects previously described experiences, with increased frailty (median Clinical Frailty Scale score of 5) and extensive comorbidity burden. This brief report provides clinicians with a contemporaneous overview of our experience, knowledge and pattern recognition when caring for people with Covid-19 and highlights the value of proactive identification of patients and risk of deterioration and palliation.","J Pain Symptom Manage","Turner, Jennifer","Eliot Hodgson, Luke","Leckie, Todd","Eade, Lisa","Ford-Dunn, Suzanne","32387139"],"abstract":["The current Covid-19 pandemic has put significant strain on all aspects of healthcare delivery, including palliative care services. Given the high mortality from this disease, particularly in the more vulnerable members of society, it is important to examine how best to deliver a high standard of end of life care during this crisis. This case series collected data from two acute hospitals examining the management of patients diagnosed with Covid-19 who subsequently died (n=36) and compared this to national and local end of life audit data for all other deaths. Our results demonstrated a shorter dying phase (38.25 hours vs 74 hours) and higher rates of syringe driver use (72% vs 33% in local audits), although with similar average mediation doses. Of note was the significant heterogeneity in the phenotype of deterioration in the dying phase, two distinct patterns emerged, with one group demonstrating severe illness with a short interval between symptom onset and death and another group presenting with a more protracted deterioration. This brief report suggests a spectrum of mode of dying. Over all the cohort reflects previously described experiences, with increased frailty (median Clinical Frailty Scale score of 5) and extensive comorbidity burden. This brief report provides clinicians with a contemporaneous overview of our experience, knowledge and pattern recognition when caring for people with Covid-19 and highlights the value of proactive identification of patients and risk of deterioration and palliation."],"journal":"J Pain Symptom Manage","authors":["Turner, Jennifer","Eliot Hodgson, Luke","Leckie, Todd","Eade, Lisa","Ford-Dunn, Suzanne"],"date":"2020-05-11T11:00:00Z","year":2020,"_id":"32387139","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.jpainsymman.2020.04.031","keywords":["covid-19","end of life care","frailty","palliative care","symptom management"],"topics":["Prevention"],"weight":1,"_version_":1666428892765749248,"score":209.90297},{"pmid":32501147,"title":"Geriatric Health in Bangladesh during COVID-19: Challenges and Recommendations.","text":["Geriatric Health in Bangladesh during COVID-19: Challenges and Recommendations.","The novel coronavirus disease (COVID-19) is impacting health globally, whereas older adults are highly susceptible and more likely to have adverse health outcomes. In Bangladesh, the elderly population has been increasing over the past few decades, who often live with poor socioeconomic conditions and inadequate access to healthcare services. These disparities are likely to increase amid COVID-19, which may result in high mortality and morbidity among Bangladeshi older adults. We recommend that multifaceted interventions should be adopted for strengthening social care and health systems approach to ensure wellbeing, promote preventive measures, and facilitate access to healthcare among older adults in Bangladesh. Such multipronged measures would require policy-level commitment and collaborative efforts of health and social care providers and institutions to protect health and wellbeing among this vulnerable population during the COVID-19 pandemic.","J Gerontol Soc Work","Hossain, Md Mahbub","Mazumder, Hoimonty","Tasnim, Samia","Nuzhath, Tasmiah","Sultana, Abida","32501147"],"abstract":["The novel coronavirus disease (COVID-19) is impacting health globally, whereas older adults are highly susceptible and more likely to have adverse health outcomes. In Bangladesh, the elderly population has been increasing over the past few decades, who often live with poor socioeconomic conditions and inadequate access to healthcare services. These disparities are likely to increase amid COVID-19, which may result in high mortality and morbidity among Bangladeshi older adults. We recommend that multifaceted interventions should be adopted for strengthening social care and health systems approach to ensure wellbeing, promote preventive measures, and facilitate access to healthcare among older adults in Bangladesh. Such multipronged measures would require policy-level commitment and collaborative efforts of health and social care providers and institutions to protect health and wellbeing among this vulnerable population during the COVID-19 pandemic."],"journal":"J Gerontol Soc Work","authors":["Hossain, Md Mahbub","Mazumder, Hoimonty","Tasnim, Samia","Nuzhath, Tasmiah","Sultana, Abida"],"date":"2020-06-06T11:00:00Z","year":2020,"_id":"32501147","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1080/01634372.2020.1772932","keywords":["aging","bangladesh","coronavirus","covid-19","geriatrics","older adults"],"locations":["Bangladesh","Bangladesh","Bangladesh"],"countries":["Bangladesh"],"countries_codes":["BGD|Bangladesh"],"topics":["Prevention"],"weight":1,"_version_":1668890966437658624,"score":194.96638},{"pmid":32430627,"title":"COVID-19-associated cardiovascular morbidity in older adults: a position paper from the Italian Society of Cardiovascular Researches.","text":["COVID-19-associated cardiovascular morbidity in older adults: a position paper from the Italian Society of Cardiovascular Researches.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infects host cells following binding with the cell surface ACE2 receptors, thereby leading to coronavirus disease 2019 (COVID-19). SARS-CoV-2 causes viral pneumonia with additional extrapulmonary manifestations and major complications, including acute myocardial injury, arrhythmia, and shock mainly in elderly patients. Furthermore, patients with existing cardiovascular comorbidities, such as hypertension and coronary heart disease, have a worse clinical outcome following contraction of the viral illness. A striking feature of COVID-19 pandemics is the high incidence of fatalities in advanced aged patients: this might be due to the prevalence of frailty and cardiovascular disease increase with age due to endothelial dysfunction and loss of endogenous cardioprotective mechanisms. Although experimental evidence on this topic is still at its infancy, the aim of this position paper is to hypothesize and discuss more suggestive cellular and molecular mechanisms whereby SARS-CoV-2 may lead to detrimental consequences to the cardiovascular system. We will focus on aging, cytokine storm, NLRP3/inflammasome, hypoxemia, and air pollution, which is an emerging cardiovascular risk factor associated with rapid urbanization and globalization. We will finally discuss the impact of clinically available CV drugs on the clinical course of COVID-19 patients. Understanding the role played by SARS-CoV2 on the CV system is indeed mandatory to get further insights into COVID-19 pathogenesis and to design a therapeutic strategy of cardio-protection for frail patients.","Geroscience","Moccia, F","Gerbino, A","Lionetti, V","Miragoli, M","Munaron, L M","Pagliaro, P","Pasqua, T","Penna, C","Rocca, C","Samaja, M","Angelone, T","32430627"],"abstract":["Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infects host cells following binding with the cell surface ACE2 receptors, thereby leading to coronavirus disease 2019 (COVID-19). SARS-CoV-2 causes viral pneumonia with additional extrapulmonary manifestations and major complications, including acute myocardial injury, arrhythmia, and shock mainly in elderly patients. Furthermore, patients with existing cardiovascular comorbidities, such as hypertension and coronary heart disease, have a worse clinical outcome following contraction of the viral illness. A striking feature of COVID-19 pandemics is the high incidence of fatalities in advanced aged patients: this might be due to the prevalence of frailty and cardiovascular disease increase with age due to endothelial dysfunction and loss of endogenous cardioprotective mechanisms. Although experimental evidence on this topic is still at its infancy, the aim of this position paper is to hypothesize and discuss more suggestive cellular and molecular mechanisms whereby SARS-CoV-2 may lead to detrimental consequences to the cardiovascular system. We will focus on aging, cytokine storm, NLRP3/inflammasome, hypoxemia, and air pollution, which is an emerging cardiovascular risk factor associated with rapid urbanization and globalization. We will finally discuss the impact of clinically available CV drugs on the clinical course of COVID-19 patients. Understanding the role played by SARS-CoV2 on the CV system is indeed mandatory to get further insights into COVID-19 pathogenesis and to design a therapeutic strategy of cardio-protection for frail patients."],"journal":"Geroscience","authors":["Moccia, F","Gerbino, A","Lionetti, V","Miragoli, M","Munaron, L M","Pagliaro, P","Pasqua, T","Penna, C","Rocca, C","Samaja, M","Angelone, T"],"date":"2020-05-21T11:00:00Z","year":2020,"_id":"32430627","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1007/s11357-020-00198-w","keywords":["acute myocardial injury","aging","covid-19","cardiovascular system","frailty","sars-cov-2"],"locations":["hypoxemia"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1667342288203808768,"score":172.61867},{"pmid":32292226,"pmcid":"PMC7129713","title":"[Coronavirus: the geriatric emergency of 2020. Joint document of the Geriatric Cardiology Section of the Spanish Society of Cardiology and the Spanish Society of Geriatrics and Gerontology].","text":["[Coronavirus: the geriatric emergency of 2020. Joint document of the Geriatric Cardiology Section of the Spanish Society of Cardiology and the Spanish Society of Geriatrics and Gerontology].","SARS-CoV2 infection, also known as COVID-19 (coronavirus infectious disease-19), was first identified in December 2019. In Spain, the first case of this infection was diagnosed on 31 January, 2020 and, by 30 March 2020, has caused 7340 deaths, especially in the elderly. Due to the rapidly evolving situation regarding this disease, the data reported in this article may be subject to modifications. The older population are particularly susceptible to COVID-19 infection and to developing severe disease. The higher morbidity and mortality rates in older people have been associated with comorbidity, especially cardiovascular disease, and frailty, which weakens the immune response. Due to both the number of affected countries and the number of cases, the current situation constitutes an ongoing pandemic and a major health emergency. Because Spain has one of the largest older populations in the world, COVID-19 has emerged as a geriatric emergency. This document has been prepared jointly between the Geriatric Cardiology Section of the Spanish Society of Cardiology and the Spanish Society of Geriatrics and Gerontology.","Rev Esp Cardiol","Bonanad, Clara","Garcia-Blas, Sergio","Tarazona-Santabalbina, Francisco Jose","Diez-Villanueva, Pablo","Ayesta, Ana","Fores, Juan Sanchis","Vidan-Austiz, Maite","Formiga, Francesc","Ariza-Sole, Albert","Martinez-Selles, Manuel","32292226"],"abstract":["SARS-CoV2 infection, also known as COVID-19 (coronavirus infectious disease-19), was first identified in December 2019. In Spain, the first case of this infection was diagnosed on 31 January, 2020 and, by 30 March 2020, has caused 7340 deaths, especially in the elderly. Due to the rapidly evolving situation regarding this disease, the data reported in this article may be subject to modifications. The older population are particularly susceptible to COVID-19 infection and to developing severe disease. The higher morbidity and mortality rates in older people have been associated with comorbidity, especially cardiovascular disease, and frailty, which weakens the immune response. Due to both the number of affected countries and the number of cases, the current situation constitutes an ongoing pandemic and a major health emergency. Because Spain has one of the largest older populations in the world, COVID-19 has emerged as a geriatric emergency. This document has been prepared jointly between the Geriatric Cardiology Section of the Spanish Society of Cardiology and the Spanish Society of Geriatrics and Gerontology."],"journal":"Rev Esp Cardiol","authors":["Bonanad, Clara","Garcia-Blas, Sergio","Tarazona-Santabalbina, Francisco Jose","Diez-Villanueva, Pablo","Ayesta, Ana","Fores, Juan Sanchis","Vidan-Austiz, Maite","Formiga, Francesc","Ariza-Sole, Albert","Martinez-Selles, Manuel"],"date":"2020-04-16T11:00:00Z","year":2020,"_id":"32292226","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1016/j.recesp.2020.03.027","keywords":["cvd, cardiovascular disease","icu, intensive care unit"],"locations":["Spain","Spain"],"countries":["Spain"],"countries_codes":["ESP|Spain"],"topics":["Prevention"],"weight":1,"_version_":1666138494407278592,"score":163.1614}]}